#nephrology — Tuesday, September 01, 2026 (1 items)
| 0 | ℹ |
In adults with CKM syndrome, finerenone vs. placebo reduced sudden death at a median 2.9 y.
(acpjournals.org)
|
Annals of Internal Medicine 2026-09-01 | #clinical trial #cardiology #nephrology #mortality |